FDA inspection
Eurofins BioPharma Product Testing Hamburg GmbH: FDA inspection ending Oct 19, 2022
FDA inspection 1288412 · Voluntary Action Indicated (VAI) · Hamburg
Key facts
| Inspection ID | 1288412 |
|---|---|
| Firm | Eurofins BioPharma Product Testing Hamburg GmbH |
| FEI number | 3010166293 |
| Address | Am Neulander Gewerbepark 2 |
| City | Hamburg |
| Country | Germany |
| Fiscal year | 2023 |
| Inspection end date | Oct 19, 2022 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data